논문KCI 등재
Response to comment on “New therapeutic agents in diabetic nephropathy”
2
조회
0
다운로드
0
인용
0
참고문헌
주제분류내과학
초록
Thank you for your interest in the article entitled “New therapeutic agents in diabetic nephropathy” [1] and your comments on erroneous information therein. We agree that there are several errors in the article; therefore, we have made the following revisions according to your comments.
Abstract
Thank you for your interest in the article entitled “New therapeutic agents in diabetic nephropathy” [1] and your comments on erroneous information therein. We agree that there are several errors in the article; therefore, we have made the following revisions according to your comments.
참고문헌 (5)
- 김예니, "New therapeutic agents in diabetic nephropathy", The Korean Journal of Internal Medicine, 32(1), pp.11~25 (2017), 대한내과학회[DOI]
- Lindhardt M, "Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY):essential study design and rationale of a randomised clinical multicentre trial", BMJ Open, 6, pp.e010310~ (2016)
- Katayama S, "A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy", J Diabetes Complications, 31, pp.758~765 (2017)
- Sato N, "A randomized controlled study of finerenone vs. eplerenone in Japanese patients with worsening chronic heart failure and diabetes and", or chronic kidney disease, 2016, pp.80, 1113~1122
- Kolkhof P, "Nonsteroidal antagonists of the mineralocorticoid receptor", Curr Opin Nephrol Hypertens, 24, pp.417~424 (2015)
관련 논문AI추천
New therapeutic agents in diabetic nephropathy김예니, 박철휘대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제1호Treatment of diabetic kidney disease: current and future targets김미경대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제4호Comment on “New therapeutic agents in diabetic nephropathy”Alain Gay, Peter Kolkhof대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제3호당뇨병성 신증의 최신 치료 -새로운 약제를 중심으로-박철휘대한내과학회 · 대한내과학회지2009 · 제77권 제6호Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs김상수, 김효진, 송상헌대한내과학회 · The Korean Journal of Internal Medicine2022 · 제37권 제3호The role of inflammation in diabetic kidney diseaseJu-Young Moon, Su Woong Jung대한내과학회 · The Korean Journal of Internal Medicine2021 · 제36권 제4호
이 간행물의 다른 논문 (29건)
Approach to cytomegalovirus infections in patients with ulcerative colitis진윤태, 진윤미, 박성철pp. 383-392Practical management of peripartum cardiomyopathy김미정, 신미승pp. 393-403Diabetic cardiomyopathy: where we are and where we are going김재택, 이왕수pp. 404-421Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?최진혁, 최용원pp. 422-428Infection in systemic lupus erythematosus, similarities, and differences with lupus flare정주양, 서창희pp. 429-438